Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 9Phase 1/2 6Phase 1 6Phase NA 3Phase 2/3 3Phase 4 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Endocrine 1CNS 1

Conditions

Triple Negative Breast Neoplasms 1Pheochromocytoma 1Neuroblastoma 1Breast Neoplasms 1

Interventions

Standard of Care 176Blood Specimen Collection 135Exercise 121Educational Status 114Methods 108Interviews as Topic 106Surveys and Questionnaires 105Practice Guidelines as Topic 105Early Intervention, Educational 93Magnetic Resonance Spectroscopy 79Specimen Handling 78Radiosurgery 68Radiotherapy 54Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 34Resistance Training 33Therapeutics 32Surgical Procedures, Operative 31Drug Therapy 31Diet Therapy 30Behavior Therapy 29Counseling 28Proton Therapy 25Acupuncture Therapy 25Nutrition Assessment 24Exercise Test 24Magnetic Resonance Imaging 23Health Promotion 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × pegfilgrastim × 1 year × Clear all
NCT07525869 2026-04-20

An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy

Yonsei University

Phase NA Recruiting
40 enrolled
Breast

Triple Negative Breast Neoplasms

NCT05296317 2026-02-19

EMEG-ECDD

Centre Georges Francois Leclerc

Phase NA Completed
97 enrolled
Breast

Breast Neoplasms

NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed
15 enrolled
CNSEndocrine

Neuroblastoma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡